Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury.
Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury.
复制标题
DOI:
10.1155/2012/219319
复制
发表时间:
2012
期刊:
影响因子:
2.9
通讯作者:
Sauvant C
中科院分区:
文献类型:
--
作者:
Betz B;Schneider R;Kress T;Schick MA;Wanner C;Sauvant C
Background. Nitric oxide (NO)-signal transduction plays an important role in renal ischemia/reperfusion (I/R) injury. NO produced by endothelial NO-synthase (eNOS) has protective functions whereas NO from inducible NO-synthase (iNOS) induces impairment. Rosiglitazone (RGZ), a peroxisome proliferator-activated receptor (PPAR)-γ agonist exerted beneficial effects after renal I/R injury, so we investigated whether this might be causally linked with NOS imbalance. Methods. RGZ (5 mg/kg) was administered i.p. to SD-rats (f) subjected to bilateral renal ischemia (60 min). Following 24 h of reperfusion, inulin- and PAH-clearance as well as PAH-net secretion were determined. Morphological alterations were graded by histopathological scoring. Plasma NOx-production was measured. eNOS and iNOS expression was analyzed by qPCR. Cleaved caspase 3 (CC3) was determined as an apoptosis indicator and ED1 as a marker of macrophage infiltration in renal tissue. Results. RGZ improves renal function after renal I/R injury (PAH-/inulin-clearance, PAH-net secretion) and reduces histomorphological injury. Additionally, RGZ reduces NOx plasma levels, ED-1 positive cell infiltration and CC3 expression. iNOS-mRNA is reduced whereas eNOS-mRNA is increased by RGZ. Conclusion. RGZ has protective properties after severe renal I/R injury. Alterations of the NO pathway regarding eNOS and iNOS could be an explanation of the underlying mechanism of RGZ protection in renal I/R injury.
登录
查看更多内容
影响因子:
3.9
作者:
Canuelo, A.;Siles, E.;Martinez-Lara, E.
通讯作者:
Martinez-Lara, E.
影响因子:
--
作者:
Sauvant, Christoph;Schneider, Reinhard;Gekle, Michael
通讯作者:
Gekle, Michael
DOI:
10.1152/ajprenal.00341.2005
发表时间:
2006-05-01
影响因子:
4.2
作者:
Du, CG;Guan, QN;Jevnikar, AM
通讯作者:
Jevnikar, AM
影响因子:
2.2
作者:
Chen, Hui;Xing, Bianzhi;Chen, Zhiyuan
通讯作者:
Chen, Zhiyuan
影响因子:
9.5
作者:
Gonon, Adrian T.;Bulhak, Aliaksandr;Pernow, John
通讯作者:
Pernow, John